Parasitic nematodes infect hundreds of millions of people and farmed livestock. Further, plant 22 parasitic nematodes result in major crop damage. The pipeline of therapeutic compounds is limited 23 and parasite resistance to the existing anthelmintic compounds is a global threat. We have developed 24 an INVertebrate Automated Phenotyping Platform (INVAPP) for high-throughput, plate-based 25 chemical screening, and an algorithm (Paragon) which allows screening for compounds that have an 26 effect on motility and development of parasitic worms. We have validated its utility by determining 27 the efficacy of a panel of known anthelmintics against model and parasitic nematodes: Caenorhabditis 28 elegans, Haemonchus contortus, Teladorsagia circumcincta, and Trichuris muris. We then applied 29 the system to screen the Pathogen Box chemical library in a blinded fashion and identified known 30 anthelmintics, including tolfenpyrad, auranofin, and mebendazole and 14 compounds previously 31 undescribed as anthelmintics, including benzoxaborole and isoxazole chemotypes. This system offers 32 an effective, high-throughput system for the discovery of novel anthelmintics. 33
Parasitic nematodes infect around one billion people, with the soil transmitted nematodes Ascaris, 35 hookworm and whipworm (Trichuris trichiura) each afflicting hundreds of millions of people (Hotez, 36 2013 ). These diseases cause high morbidity and are closely linked to poverty in the developing world. 37
The global impact of parasitic nematodes is worsened by their effect on livestock, equids and 38 companion animals. Parasitic nematodes of livestock are thought to cost approximately $10 billion 39 annually with anthelmintic products comprising a major segment of the veterinary pharmaceuticals 40 market (Roeber et al., 2013) . 41
There are concerns that mass drug administration (MDA) programs aimed at controlling or 42 eradicating human parasitic nematodes will become unsustainable by anthelmintic resistance, 43 jeopardising attempts to eradicate these important tropical diseases (Prichard et al., 2012) . In the case 44 of Trichuris, modelling indicates that existing benzimidazole drugs are insufficiently effective for 45 single dose MDA programs designed to break transmission; therefore eradication cannot be achieved 46 (Keiser J and Utzinger J, 2008; Levecke et al., 2014; Turner et al., 2016) . The current arsenal of 47 veterinary anthelmintics is threatened by the emergence and spread of resistance in parasitic 48 nematodes of domesticated animals, a recent example of which is the report of resistance to 49 monepantel in sheep nematode species only four years after introduction of the compound (Scott et 50 al., 2013) . Multi-class resistance is also common in parasitic nematodes of ruminants (Rose et al., 51 2015; Sutherland, 2015) and equids (Matthews, 2014) . Thus, there is an urgent requirement for the 52 identification of novel classes of anthelmintics. 53
Phenotypic screening is enjoying a resurgence in recent years, and is playing an increasingly 54 important role in the modern drug discovery paradigm (Al-Ali, 2016). Furthermore, employment of 55 this approach using live nematodes ex vivo has been historically successful for target identification 56 and lead optimisation. For example, a series of acetonitrile derivatives were identified using a 57
Haemonchus. contortus in vitro larval development assay, and this led to the discovery of monepantel 58 (Kaminsky et al., 2008) . 59
Automated systems for phenotypic screening of parasitic nematodes and models of parasites 60
Given the need for new anthelmintics, there has been growing interest both in phenotypic screens for 61 identification of new classes of active small molecules and in systems for quantifying relevant 62 readouts of nematode viability such as growth and motility (Buckingham et al., 2014; Buckingham 63 and Sattelle, 2008) . Manual scoring of motility, growth or viability has been effective and used to 64 screen libraries of up to 67,000 compounds (Burns et al., 2015; Tritten et al., 2011 Tritten et al., , 2012 . Automated 65 systems offer the potential of higher throughput and greater reliability. Such approaches include 66 indirect assessment of viability by using the xCELLigence System; assessment of metabolic activity 67 via colorimetric assays such as resazurin, MTT, and acid phosphatase activity; assessment of motor 68 activity via isothermal microcalorimetry and quantification of movement-related light scattering 69 (Nutting et al., 2015; Silbereisen et al., 2011; Smout et al., 2010; Wangchuk et al., 2016a Wangchuk et al., , 2016b . 70
Imaging-based systems for quantification of motility or growth have also been developed. The 71 "WormAssay" system quantifies the motility of macroscopic parasites such as Brugia malayi adult 72 worms (Marcellino et al., 2012) . This system has been further developed into "The Worminator", 73 which quantifies smaller, microscopic nematode stages and has been validated by quantifying the 74 activity of several anthelmintics (Storey et al., 2014) . This system has a reported scan time of 30 75 seconds per well, hence a throughput of around one and a quarter 6-well plates per hour. A system 76 based on single-well imaging and thresholding of motile pixels with a throughput of around five 96-77 well plates per hour has been reported (Preston et al., 2016a) . Its utility has been demonstrated by the 78 successful screening of a 522-compound kinase inhibitor library and the 400-compound Medicine for 79 Malaria Venture Pathogen box on Haemonchus contortus larvae (Preston et al., 2015 (Preston et al., , 2016b . A 80 notable recently-described screen of the effects of 26000 compounds on Caenorhabditis elegans 81 growth/survival used WormScan, a system that uses a conventional flat-bed scanner to capture two 82 frames of images of whole plates and then uses an algorithm based on the difference image to assign a 83 value to each well that reflects motility/growth (Mathew et al., 2012 (Mathew et al., , 2016 organism under study and is specified below. Movies were analysed using MATLAB scripts. Briefly, 115 movies were analysed by calculating the variance through time for each pixel. The distribution of 116 these pixel variances was then considered, and pixels whose variance was above the threshold 117 (typically those greater than one standard deviation away from the mean variance) were considered 118 'motile'. Motile pixels were then counted and assigned by well, generating a movement score for each 119 well. The source code for this software has been released under the open source MIT license and is 120 available at https://github.com/fpartridge/invapp-paragon. A further MATLAB script has been 121 provided for batch processing of movies. 122
Caenorhabditis elegans motility and growth assays 123
C. elegans strains were maintained at 20 °C on nematode growth medium agar seeded with the E. coli 124 strain OP50. To obtain worms for screening, a mixed-stage liquid culture was prepared by washing 125 well-fed worms from one small NGM plate into a medium of 50 ml S-complete buffer with a pellet of 126 approximately 2-3 g E. coli HB101. Cultures were agitated at 200 rpm, 20 °C, until there were many 127 adults present, then synchronised at the L1 stage by bleaching. Fifty millilitre cultures were pelleted 128 and bleaching mix (1.5 ml 4M NaOH, 2.4 ml NaOCl, 2.1 ml water) added. Mixing for 4 minutes led 129 to the release of embryos, which were washed three times with 50 ml S-basal medium. The cultures 130 were incubated in 50 ml S-basal at 20 °C and agitated at 200 rpm overnight to allow eggs to hatch and 131 arrest as a synchronous L1 population. 132
For the growth assay, C. elegans were cultured in a 96-well plate format. Synchronised L1 were 133 diluted to approximately 20 worms per 50 µl in S complete medium with around 1% w/v HB101 E. 134 coli. Assay plates were prepared with 49 µl of S-basal and 1µl of DMSO or compound in DMSO 135 solution per well. Next, 50 µl of the L1 suspension were added to each well. Plates were incubated at 136 20°C before imaging using the INVAPP / Paragon system 5 days later. Prior to imaging, worm 137 motion was stimulated mechanically by inserting and removing a 96-well PCR plate into/from the 138 wells of the assay plate. Whole-plate 200 frame movies were recorded at 30 frames per second (7 139 seconds total). 140
For the adult motility assay, synchronised L1 were refed as a bulk 50 ml culture and cultured at 20 °C 141 until they developed into young adults. Worms were washed in S-basal and dispensed, approximately 142 20 worms per well, into 96-well plates with compound dissolved in DMSO, or DMSO alone and then 143 incubated for 3 hours. Whole-plate 200 frame movies were recorded at 30 frames per second (7 144 seconds total). 145
Trichuris muris motility assay 146
For the adult T. muris motility assay, male and female severe combined immune deficiency mice 147 (bred in the Biological Services Facility at the University of Manchester) were infected with 200 148 embryonated T. muris eggs in water by oral gavage. After 35 days, mice were killed and their caecae 149 and colons removed, opened longitudinally, and washed with pre-warmed Roswell Park Memorial 150 Institute (RPMI) 1640 media supplemented with penicillin (500 U/ml) and streptomycin (500 µg/ml). 151
Adult T. muris worms were then removed using fine forceps and maintained in RPMI-152 1640/penicillin/streptomycin media at approximately 37 ºC and studied on the same day. Individual 153 live worms were placed into 96 well plates containing 75 µl of RPMI-1640/penicillin/streptomycin 154 medium plus 1% v/v final concentration of DMSO or compound dissolved in DMSO. Plates were 155 incubated at 37 °C, 5% v/v CO 2 , and motility was analysed after 24 hours. Whole plate 200 frame 156 movies were recorded at 10 frames per second (20 seconds total). 157
Ovine parasitic nematode isolation 158
Six month-old, male Texel cross lambs that were raised under helminth-free conditions were infected 159 per os either with 15,000 T. circumcincta (isolate MTci2) larvae (L 3 ) or 5,000 H. contortus (isolate 160 MHco3) L 3 . Once a patent infection was detected by the observation of nematodes eggs in faeces 161 (around 21 days post-infection), the lambs were fitted with a collection harness and bag to enable 162 faecal collection. Pelleted faeces were collected from each bag 24 hours later and placed in a covered 163 seed tray, which was incubated at room temperature (>15 ºC) for 10 days before larval recovery using 164 the modified Baermann technique (Manual of veterinary parasitological laboratory techniques., 165 1986). The next day L 3 were recovered in ~250 ml H 2 O, number estimation performed then the larvae 166 were stored in 100 ml tap water in 75 cm 2 surface area vented cap, suspension culture flasks (Sarstedt 167
Ltd UK) at ~ 5 °C for MTci2 and 8 °C for MHco3, respectively. 
Results 196

INVAPP / Paragon: a high-throughput assay for quantifying nematode motility and growth 197
We wanted to develop an assay for screening small molecules for their effect on the motility and 198 growth of diverse parasites. A high-throughput and automated system was particularly desirable, 199
given the large size of available small molecule libraries. To this end, we designed the INVAPP / We took a statistical approach to quantifying motility. The variance through time for each pixel in the 227 plate was calculated and the distribution of the variances examined. Pixels whose variance is greater 228 than a threshold of the mean plus typically one standard deviation are determined to be "motile" (Fig  229   1B ). For organisms that are particularly small or have limited motility, such as H. contortus L3s, this 230 threshold was increased to the mean plus two standard deviations, reflecting a lower prior expectation 231 of worm movement in the movie. A similar approach was recently reported for the determination of 232 H. contortus motility (Preston et al., 2015) . An example of this thresholding model is shown in Fig  233   1C , which shows analysis of a 96-well plate containing adult C. elegans. Dark pixels are those that 234 have been determined to be motile. Once the motility threshold has been applied to the data, 'motile' 235 pixels are assigned by well to their plate location and counted. All analysis is fully automated via a set 236 of MATLAB scripts, available at https://github.com/fpartridge/invapp-paragon. 237
This approach was able to determine motility. To illustrate this, we analysed plates containing a 238 variable number of synchronized adult C. elegans worms. As expected, quantified movement 239 increased with the number of worms per well, reflecting a larger number of 'motile' pixels in the 240 recording ( Fig 1D) . 241
The system was also able to quantify nematode growth. To test this, we synchronised C. elegans at 242 the L1 stage, before refeeding them in plates at two temperatures commonly used in C. elegans 243 culture (20 °C and 25 °C). Plates were then analysed using INVAPP / Paragon every 24 hours. The 244 results are shown in Fig 1E. The quantified movement index increases as worms develop from L1 to 245 adult stage. The drop in motility in the 25 °C group on day 5 reflects growth of L1 progeny leading to 246 exhaustion of the bacterial food source and starvation. 247
When establishing a high-throughput assay it is important to consider the issue of edge effects (Malo 248 et al., 2006) . Systematic biases across the plate are particularly common around edges. Typical causes 249 are evaporation, which is often worse at the edges, or temperature inhomogeneity. In our assay, given 250 that it involves imaging of whole plates, we also wanted to exclude the possibility of systemic bias 251 caused by optical distortion. To address these concerns, we analysed a 1920-well C. elegans growth 252 dataset. This was chosen because the long four-day incubation time gave the maximum possibility of 253 confounding evaporation differences. We classified wells on the outer rows and columns of the plate 254 as being outer wells, and compared their quantified motility to the inner wells ( Fig 1F) . There was no 255 significant difference between these groups (Mann-Whitney-Wilcoxon test, P=0.77), and therefore no 256 evidence of problematic edge effects in this assay. To further exclude the possibility of assay 257 inhomogeneity across the plate, we calculated a heat map showing average normalised motility for 258 each well ( Fig 1G) . Again, this showed no evidence of systemic bias by plate position. 259
Validation of the INVAPP / Paragon assay using existing commercial anthelmintic 260 standards 261
Having set up this high-throughput motility and growth assay, we wanted to validate its utility by 262 examining the effects of a panel of known anthelmintics. We selected nine anthelmintics with a 263 variety of reported mechanisms of action. Piperazine is a GABA agonist that acts at the 264 neuromuscular junction (Martin, 1985) . Diethylcarbamazine has been proposed to have a similar 265 mechanism, although other mechanisms including targeting host arachidonic acid metabolism are also 266 thought to be important (Maizels and Denham, 1992) . Levamisole, oxantel and pyrantel are nicotinic 267 acetylcholine receptor agonists that induce spastic paralysis (Martin et al., 1997) . Mebendazole is an 268 inhibitor of beta-tubulin polymerisation (Driscoll et al., 1989) . Ivermectin is a positive allosteric 269 modulator of glutamate-gated chloride channels although other targets have also been suggested 270 (Cully et al., 1994) . Trichlorfon is a member of the organophosphate group of acetylcholine esterase 271 inhibitors. Praziquantel is thought to act by disrupting calcium ion homeostasis but its target is unclear 272 (Caffrey, 2007) 
Adaptation of the INVAPP / Paragon assay to parasitic nematodes 302
C. elegans is a useful model because of the ease of laboratory culture and access to powerful genetic 303 tools. However, it is also valuable to screen parasitic nematodes directly. T. circumcincta is a globally 304 important parasitic nematode that infects small ruminants. We tested the ability of the INVAPP / 305
Paragon system to quantify the activity of the anthelmintic ivermectin on ensheathed T. circumcincta 306 L3. Worms were incubated at 25 °C with the compounds for 2 hours in the dark, after which 307 movement was induced by bright light and movies recorded on the INVAPP system. Fig 4A shows an 308 example of the INVAPP / Paragon motility thresholding of single wells treated with DMSO or DMSO 309 plus 100 µM ivermectin, showing much reduced, but not abolished movement, of these larvae in the 310 assay. We obtained a concentration-response curve for ivermectin ( Fig 4B) , demonstrating the ability 311 of the system to quantify motility of this parasite. Fig 6B, showing the quantification of the loss of motility of the levamisole-treated worm. A concentration-response curve 347 for levamisole was measured ( Fig 6C) , which illustrates the ability of the system to quantify motility 348 of this parasite and thus measure anthelmintic activity. We first considered known anthelmintic compounds that we found to be active in this screen (Table  396 1). Mebendazole, an anthelmintic from the benzimidazole group, acts by inhibiting microtubule 397 synthesis. Tolfenpyrad is a broad-spectrum acaricide and insecticide that acts as an inhibitor of 398 complex I of the electron transport chain. It has been recently reported to reduce motility of H. 399 contortus exsheathed L3 and to block L3 to L4 development of this parasite in vitro (Preston et al., 400 2016b) . We confirmed activity of this compound using solid material. As shown in Fig 7C, Tavaborole n/a 11499245 n/a n/a 8.6 ± 1.9
409
Auranofin is a gold(I) compound originally developed for the treatment of rheumatoid arthritis. It has 410 received attention for repurposing as an anti-cancer agent, with a number of clinical trials under way. 411
It has been shown that auranofin has in vitro and in vivo activity in several models of parasitic 412 Isradipine is an antihypertensive drug that belongs to the dihydropyridine family of L-type calcium 418 channel blockers. A structurally related dihydropyridine, nemadipine-A, has been shown to cause 419 growth and egg laying defects in C. elegans by antagonising the L-type calcium channel α 1 -subunit 420 EGL-19 (Kwok et al., 2006) . We confirmed activity of this compound in the C. elegans growth assay 421 using solid material. As shown in Fig 7E, the EC 50 of this compound was 1.6 ± 0.7 µM. 422 423 3.6. Novel anthelmintics that block C. elegans growth 424 Fourteen compounds without previously-described anthelmintic activity were identified in the 425 Pathogen Box screen ( Table 2 ). The structures of the most active compounds are shown in Fig 8. We 426 examined four of these compounds more closely. First, we determined activity, using solid material, 427 in the C. elegans growth assay (Fig 9) . The EC 50 values for the confirmatory assay are shown in Table  428 2. These results have been recorded in the PubChem database with Assay ID 1259335. MMV007920 is a benzoxazole-containing compound previously identified in a screen for agents that 447
inhibit Plasmodium falciparum proliferation. The target of this compound is not known but it has 448 been suggested that some benzoxazole compounds act on beta-tubulin (Satyendra et al., 2011). 449 MMV020152 is an isoxazole-containing compound previously identified in a screen for compounds 450 that inhibit P. falciparum growth. A number of other compounds also containing isoxazole motifs 451 have been shown to have insecticidal activity (da Silva-Alves et al., 2013). MMV688372 is an 452 imidazopyridine-containing compound that has been previously shown to have in vivo anti-453 trypanosomal activity (Tatipaka et al., 2014) . 454 MMV652003 is a benzoxaborole-containing compound that has also been given the identifier 455 AN3520 in the literature. This compound has potent activity against Trypanosoma sp., both in vitro, 456 and in murine models of human African trypanosomiasis (Nare et al., 2010) . In this context this 457 compound has been iteratively improved leading to the identification of the close relative SCYX-7158 458 (Jacobs et al., 2011) , which is currently in clinical trials. The anti-trypanosomal target of this 459 benzoxaborole class is not known (Jones et al., 2015) . A simpler benzoxaborole compound, 460 tavaborole ( Fig 10B) , has been approved as an anti-fungal (Elewski et al., 2015) . This acts by 461 inhibiting cytoplasmic leucyl-tRNA synthetase by forming an adduct with tRNA Leu in the enzyme 462 editing site (Rock et al., 2007) Given the effect of MMV652003 and the similarity of this compound to the already approved drug 473 tavaborole, we determined whether tavaborole was effective in the C. elegans growth assay. 474
Tavaborole showed concentration-dependent growth inhibition ( Fig 10C) with an EC 50 of 8.6 ± 1.9 475 µM (Table 1) . This is similar to that of the benzoxaborole screen hit, MMV652003, which has an 476 EC 50 of 4.3 ± 2.5 µM (Table 1) . These results support the development of a benzoxaborole anti-477 nematode agent. 478
Discussion 479
There is an urgent need for new anthelmintics. Despite encouraging progress with MDA programs, 480 current strategies and therapies will not achieve eradication of, for example, T. trichiura (Keiser J and 481 Utzinger J, 2008; Turner et al., 2016) . Furthermore, MDA, particularly with drugs that do not fully 482 clear infection, may lead to drug resistance (Vercruysse et al., 2011) . The experience from veterinary 483 parasitology is that resistance to new anthelmintics can develop relatively rapidly after registration, 484 causing major economic impacts and risks to global food security (Scott et al., 2013) . 485
In this manuscript, we present the INVAPP / Paragon system which, based on imaging of whole 486 microplates and thresholding pixel variance to determine motion, is able to quantify growth and/or 487 motility of parasitic nematodes and the free-living nematode, C. elegans. A strength of this system is 488 its high-throughput capability, typically imaging a whole plate for 5-20 seconds is sufficient to 489 reliably quantify motion in all 96 wells. We demonstrated this effect by determining efficacy of a 490 panel of anthelmintics in both acute motility and growth assays in C. elegans and of known 491 anthelmintics in H. contortus, T. circumcincta, and T. muris assays. We further demonstrated utility of 492 the system in a screen of small molecules for compounds that block or limit C. elegans growth. 493
Current anthelmintic screens generally focus on motility reduction, as growth of parasitic nematodes 494
can be difficult to model in vitro, with larvae failing to moult through their larval stages outside of the 495 host. However anthelmintic activity in vivo can be much broader than inhibition of motility and thus 496 screening compounds for their ability to inhibit C. elegans growth, rather than motility, represents a 497 useful strategy to identify compounds which can subsequently be tested for growth inhibition activity 498 in vivo. We used the Pathogen Box, a library of a collection of 400 diverse drug-like molecules known 499 to be active against various neglected diseases, distributed as an open-science project by the 500 Medicines for Malaria Venture. 501
Identifying the known anthelmintics mebendazole and tolfenpyrad (Preston et al., 2016b) using 502 independent blinded screening approach serves as an important validation and supports the robustness 503 of the screening platform. Repurposing of existing drugs for new indications is an established 504 approach in drug discovery (Zheng et al., 2017) and is particularly valuable for neglected tropical 505 diseases as it may reduce research and development costs and speed progress to clinical trials 506 (Pollastri and Campbell, 2011 ). Auranofin has recently been shown to have activity against filarial 507 nematode infection (Bulman et al., 2015) . Our identification of auranofin as a compound that blocks 508 C. elegans growth lends support to test repurposing of this compound for nematode infections. 509
Isradipine, a safe and well-tolerated L-type calcium channel blocker, was also active in the screen. 510
Assaying the activity of isradipine in in vivo models of parasitic infection is a priority and could lead 511 to repurposing trials. 512
We also identified 14 compounds with previously undescribed anthelmintic activity in the C. elegans 513 growth assay, belonging to a variety of chemical classes. These include benzoxazole results demonstrate the potential for anthelmintic discovery using this system. 528
We focused our application of the INVAPP / Paragon system to investigating parasitic diseases. 529 However, given its ability to determine growth and motility of C. elegans quickly and robustly, it 530 could also be applied to the study of other human diseases modelled in C. elegans. 531
In conclusion, we have developed a high-throughput system for measuring the growth and/or motility 532 of parasitic and free-living nematodes. Quantification of the activity of known anthelmintics and 533 identification of novel chemotypes with anthelmintic activity was demonstrated, validating our 534 approach. The system is well suited to library-scale screening of chemicals with many human and 535 animal health applications. 536 537 Acknowledgements 538
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